Search This Website

Tuesday, 30 June 2020

India Banned Tik Tok and 58 Other China App, Know Alternative to these Apps

India Banned Tik Tok and 58 Other China App, Know Alternative to these Apps

India Banned TikTok and 58 Other apps which were of china origin. This is merely in response to allegations of misuse of data, and the transfer of said data outside the country. Well sharing data outside is something which harms the sovereignty and integrity of India

Ravi Shankar Prasad, Law & Justice, Communications, Electronics & Information Technology Minister Of India said that "For safety Security, defense, sovereignty and integrity of India and to protect the data and privacy of India, the government have banned 59 mobile apps".

Alternative To banned Apps


Tik Tok
UC Browser
Clash Of Kings
YouCam Makeup
Baidu Map
Du Battery Saver
Mi community
CM Browsers
APUS Browser
Virus Cleaner
Club Factory
Beauty PLus
UC News
Es File Explorer
QQ Music
QQ Mail
QQ Newsfeed
Bigo Live
Parallel Space
Mail Master
Mi Video Call - Xiaomi
Viva Video - QU Video Inc.
Vigo Video
New Video Status
DU Recorder
Vault - Hide
Cache Cleaner DU App Studio
DU cleaner
DU browser
Hago Play with New friends
Sweet Selfie
Wonder camera
Photo Wonder
DU privacy
We Meet
Clean Master - Cheetah Mobile
Baidu translate
U Video
QQ International
QQ Security Center
QQ Launcher
V Fly Status Video
Mobile Legends
QQ Player

tiktok ban


The move, however, comes after the worst clashes in decades between the two nations , leading many to speculate it as a response to Chinese aggression at the LAC.

Moreover, the frequently used Section 69A of the IT Act, under which this was done, is not normally accompanied with announcement and is done in secret.

The announcement and the timing, along with the past precedent of such actions, may strongly suggest that it is politically motivated retaliation against China.


This move is bound to cause harm - the question, however, is who will be to carry the burden; for now, it looks like it would be the app developers and Indian consumers.

Tik Tok, for instance, would lose a 120 million Indian consumers, but countless users new to the internet who use the platform to either earn or support their businesses would also lose an invaluable platform do so.


The majority of the negative consequences would be borne by consumers and developers, with the Chinese government or China's GDP being left relatively unscathed.

Retalliation from their front is likely, but because of the motivation behind said decision; not because their economy is "hurt".

This, then, may truly be a political message and a push to the 'Aatmanirbhar Bharat' campaign as Indian counterparts of the applications get handed a comparatively competition-free industry.


Despite the larger implications, a major source of concern for the average user is having to find suitable alternatives; fortunately, these exist.

Tik Tok's Indian counterparts Chingari and Mitron are freely available on the Google Play Store and have been gaining traction; the former has 2.5 mn downloads.

Users of UC Browser and DU Browser could switch to browsers such as Safari and Google Chrome; for an Indian alterenative, the JioBrowser has a layout similar to UC.

Helo, Bigo Live, Vigo Video, VMate, Kwai

Alternative: Mitron and Chingari

UC Browser, DU Browser, Cm Browser and APUS Browser

Alternative: Google Chrome and Mozilla Firefox. Also Jio Browser.

YouCAm Makeup, BeautyPlus and Photo Wonder

Alternative: B16 - Beauty & Filter Camera

SHAREit and Xender

Alternative: Super Beam. Can also use Wifi Direct, NFC or QR codes for transfering and sharing large files.

360 Security

Alternative: Bitfender Mobile security and Antivirus


Alternative: The Norton App


Alternative: Adobe Scan, PDF scanner with OCR

ES File Explorer

Alternative: Files by Google: Clean Up space on your phone" and File Commande File Manager & Free Cloud.


Alternative: Myntra

Mi Video Call

Alternative: WhatsApp

Read More »

Thursday, 25 June 2020

Corona Virus( COVID-19) Top Vaccine Candidates

Corona Virus( COVID-19) Top Vaccine Candidates

Ever since COVID-19 outbreak, laboratories around the world have been busy creating vaccines and undergoing trials.

Several companies and governments doubled their efforts to find a permanent cure.

Apart from individual progression, world leaders and organizations, excluding the United States pledged $ 8 billion to research, manufacture and distribute a vaccine and treatment for the virus.


 Here are some of the top vaccine candidates

Ad5nCoV Vaccine 

• Adenovirus Type 5 Vector, an advanced DNA vaccine is named as the top contender for COVID-19 by the WHO.

• It's developed by using both Chinese and Canadian technology and is Co-developed by the Beijing Institute of Biotechnology Biologics Inc. (BIB) and CanSino Genetically engineered defective adenovirus type 5 vector was replication used to express the SARS-CoV-2 spike protein which  is grown using living cells.

 Remdesivir Vaccine 

• Dr. Anthony Fauci of National Institute of Allergy and Infectious Diseases (NIAID) said that the trial for Remdesivir produced a 'clear cut positive effect in diminishing time to recover.

• Vaccinated people had recovered from COVID-19 in just 11 days compared to the control group that took 15 days.

• Remdesivir has shown promising results in the treatment of other coronavirus diseases such as SARS and MERS.


• This vaccine is being developed by Oxford University and supported by the British Pharma company, Astrazeneca.

• The company stated that it would roll out up to 2 billion doses in September.

• The vaccine uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold (adenovirus) virus that causes infections in chimpanzees.  It has been modified to work on humans and contains the genetic material of SARS-COV-2 spike protein.

 • The vaccine has already progressed into phase II / III trials involving 10,000 people from the UK.  

MRNA-1273 Vaccine 

• This experimental vaccine is created by one of the leading US companies, Moderna Inc.

• The vaccine has received approval from the FDA to proceed with the phase II clinical trial.

• The phase II trial will evaluate the safety and immunogenicity of two MRNA-1273 vaccinations.

 Inovio's Vaccine 

• Before the outbreak, the company was in the process of creating a DNA vaccine for MERS.  Resultantly, developed a potential vaccine for SARS- the company swiftly CoV-2.

• The vaccine (INO-4800) targets the Spike protein, a surface antigen that causes COVID-19.

• Phase II / II clinical trials will take place this summer.


• Sanofi is developing COVID-19 vaccine with GlaxoSmithKline and Translate Bio.

• GSK's proprietary adjuvants are being used, which is a compound that boosts immune response, allowing less vaccine to be used for each person.

• Sanofi predicts to get approved by the FDA soon and states that Phase III trial for the vaccine could begin in December or January, 2021.

• Sanofi and Translate Bio have multiple MRNA vaccine candidates against COVID-19 in preclinical testing and will start a first human trial in the fourth quarter of this year.
Read More »